[1] 中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2015)[J].中华结核和呼吸杂志,2016,39(5):323-354. [2] Lai K.Chinese National Guidelines on Diagnosis and Management of Cough:consensus and controversy[J].J Thorac Dis,2014,6(Suppl 7):S683-S688. [3] Shen F,Gaffen SL.Structure-function relationships in the IL-17 receptor:implications for signal transduction and therapy[J].Cytokine,2008,41(2):92-104. [4] McKinley L,Alcorn JF,Peterson A,et al.TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice[J].J Immunol,2008,181(6):4089-4097. [5] Yang XO,Chang SH,Park H,et al.Regulation of inflammatory responses byIL-17F[J].J Exp Med,2008,205(5):1063-1075. [6] Yagami A,Orihara K,Morita H,et al.IL-33 mediates inflammatory responses in human lung tissue cells[J].J Immunol,2010,185(10):5743-5750. [7] Southcombe JH,Lédée N,Perrier d'Hauterive S,et al.Detection of soluble ST2 in human follicular fluid and luteinized granulosa cells[J].PLoS One,2013,8(9):74385. [8] Lloyd CM.IL-33 family members and asthma-bridging innate and adaptive immune responses[J].Curr Opin Immunol,2010,22(6):800-806. [9] Saenz SA,Taylor BC,Artis D.Welcome to the neighborhood:epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites[J].Immunol Rev,2008,226:172-190. [10] Schmitz J,Owyang A,Oldham E,et al.IL-33,an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J].Immunity,2005,23(5):479-490. [11] Komai-Koma M,Xu D,Li Y,et al.IL-33 is a chemoattractant for human Th2 cells[J].Eur J Immunol,2007,37(10):2779-2786. [12] Schmitz J,Owyang A,Oldham E,et al.IL-33,an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J].Immunity,2005,23(5):479-490. [13] Gour N,Wills-Karp M.IL-4 and IL-13 signaling in allergic airway disease[J].Cytokine,2015,75(1):68-78. [14] Chung KF.Chronic' cough hypersensitivity syndrome':a more precise label for chronic cough[J].Pulm Pharmacol Ther,2011,24(3):267-271. [15] Crespo A,Giner J,Torrejón M,et al.Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum[J].J Asthma,2016,53(5):459-464. [16] Neelamegan R,Saka V,Tamilarasu K,et al.Clinical utility of fractional exhaled nitric oxide (FeNO) as a biomarker to predict severity of disease and response to inhaled corticosteroid (ICS) in asthma patients[J].J Clin Diagn Res,2016,10(12):1-6. [17] Asano T,Takemura M,Fukumitsu K,et al.Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status[J].Allergol Int,2017,66(2):344-350. [18] 胡秋平,王玮,苏皎,等.阻塞性睡眠呼吸暂停低通气综合征伴高血压血清诱导型一氧化氮合成酶水平临床研究[J].中国实用内科杂志,2016,36(5):385-388. |